The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Orgenesis Inc(NASDAQ:ORGS) 
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a...
Website: http://www.orgenesis.com
Founded: 2008
Full Time Employees: 309
Sector: Healthcare
Industry: Biotechnology
Orgenesis Days Payable Outstanding ttm (DPO)
Orgenesis Days Receivable Outstanding ttm (DSO)
Orgenesis Days Inventory Outstanding ttm (DIO)
Orgenesis Op Cashflow Per Share ttm
Orgenesis Free Cashflow Per Share ttm
Orgenesis Cash Per Share ttm
Orgenesis P/S ratio ttm
Orgenesis (GAAP) P/E ratio ttm
Orgenesis P/B ratio ttm
No extra charts and metrics for this ticker.